Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure supports peptide-like frameworks, making it valuable in medicinal chemistry for creating enantiomerically pure drugs. Commonly employed in solid-phase peptide synthesis and asymmetric synthesis routes where stereochemistry is critical. Also utilized in research settings for designing enzyme inhibitors due to the substituted phenyl group influencing binding affinity and selectivity.